Key result
Valve-in-valve transcatheter tricuspid replacement with a 32 mm balloon-expandable valve successfully reduced a 7 mmHg gradient without leak and improved functional status at 4 months.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Transcatheter valve-in-valve replacement using a 32 mm balloon-expandable valve successfully resolved severe tricuspid bioprosthetic stenosis and improved functional status in a high-risk patient with Ebstein anomaly.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hanžek et al. (2026) conducted a case report in Severe degeneration of tricuspid bioprosthesis with tricuspid stenosis (n=1). Valve-in-valve transcatheter tricuspid valve replacement (ViV TTVR) with a 32 mm balloon-expandable valve was evaluated on Procedural success, transvalvular pressure gradient reduction, and clinical status. Valve-in-valve transcatheter tricuspid replacement with a 32 mm balloon-expandable valve successfully reduced a 7 mmHg gradient without leak and improved functional status at 4 months.
Synapse has enriched 10 related papers. Consider them for comparative context: